why are glp 1 bad for you GLP-1 Agonist: The Good, the and the Ugly GLP-1 Medication & Muscle Loss:

Medicare currently covers Wegovy for patients at risk of heart disease, as well as Zepbound for sleep apnea but not for weight loss alone

GLP-1 Off Label Popularity The GLP-1 weight-loss trend has gone viral as diabetes drugs like Novo Nordisk A/ S NYSE: NVO produced Ozempic and Eli Lilly and Co

The format itself may help reduce psychological barriers around starting treatment

Mounjaro was approved in 2022 for type 2 diabetes, while Zepbound was approved in 2023 specifically for chronic weight management

It has a number of side effects, but the most severe include: Pancreatitis Gallbladder issues Increased risk of low blood sugar Kidney problems Changes in vision Increased heart rate Severe allergic reactions Saxenda Saxenda is another injectable drug by Novo Nordisk and is used to treat obesity in children and adults, as well as treat weight loss in adults